— Know what they know.
Not Investment Advice

APUS AMEX

Apimeds Pharmaceuticals US, Inc
1W: -55.6% 1M: +22.4% 3M: -62.6% YTD: -80.7% 1Y: -81.2%
$3.22
-0.88 (-21.46%)
 
Weekly Expected Move ±68.6%
$-1 $1 $3 $5 $8
AMEX · Healthcare · Biotechnology · Tech Score Neutral · Power 48 · $4.9M mcap · 563192 float · 267.23% daily turnover · Short 44% of daily vol
Smart Money Score
Watch 0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$4.9M
52W Range1.51-59.7
Volume137,178
Avg Volume1,505,000
Beta0.15
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOVinod Menon
Employees7
SectorHealthcare
IndustryBiotechnology
IPO Date2025-05-09
100 Matawan Rd
Matawan, NJ 07747
US
808-209-7887
About Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

Recent Insider Trades

NameTypeSharesPriceDate
Weintraub Bennett A-Award 10,000 $2.67 2025-11-11
Yoon Hankil A-Award 10,000 $2.67 2025-11-11
Koo Jakap A-Award 10,000 $2.67 2025-11-11
O'DONNELL CAROL A A-Award 10,000 $2.67 2025-11-11
Kogan Elona A-Award 10,000 $2.67 2025-11-11

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms